Kling Bio validates its proprietary B-cell technology for rapid response against emerging viral variants: Amsterdam Wednesday, September 10, 2025, 17:00 Hrs [IST] Kling Bio, the f ...

Germinal center B-cell–like diffuse large B-cell lymphomas (GCB-DLBCLs) show dependence on DOT1L and EZH2, with combined targeting offering potential as an alternative differentiation-based therapy.

For the treatment, Lou, a 10-year-old Beagle, and Sadie, an 8-year-old Collie/Pyrenees mix received infusion with CAR-T cells isolated with Akadem’s kit. During the 3-week study, the dogs’ tumors ...

New findings show that the stage of normal cell development at which B cells transform into leukemic cells impacts treatment outcomes for pediatric patients with B-cell acute lymphoblastic leukemia (B ...

waveLINE-010: Zilovertamab vedotin plus R-CHP versus R-CHOP in untreated diffuse large B-cell lymphoma. This is an ASCO Meeting Abstract from the 2025 ASCO Annual Meeting I. This abstract does not ...

This study provides valuable insights into human valve development by integrating snRNA-seq and spatial transcriptomics to characterize cell populations and regulatory programs in the embryonic and ...

Inherited metabolic diseases are rare monogenic conditions that disrupt biochemical pathways, affecting energy production and ...